Efficacy and safety of once-weekly insulin icodec vs once-daily basal insulin in type 2 diabetes by ethnicity and race: ONWARDS 1-5

被引:0
|
作者
Lingvay, I. [1 ,2 ]
Bangsgaard, K. O. [3 ]
Desouza, C. [4 ]
Fragao-Marques, M. [3 ]
Navarria, A. [3 ]
Vianna, A. [5 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr Dallas, Peter ODonnell Jr Sch Publ Hlth, Dallas, TX 75390 USA
[3] Novo Nordisk AS, Soborg, Denmark
[4] Univ Nebraska Med Ctr, Omaha, NE USA
[5] Hosp Nossa Senhora Gracas, Curitiba Diabet Ctr, Dept Endocrine Dis, Curitiba, Parana, Brazil
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
785
引用
收藏
页码:S375 / S376
页数:2
相关论文
共 50 条
  • [21] Efficacy and hypoglycaemia outcomes with once-weekly insulin icodec versus once-daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant-level analysis of the ONWARDS 1-5 trials
    Rossing, Peter
    Benamar, Malik
    Cheng, Alice Y. Y.
    Kumar, Bharath
    Laugesen, Christian
    Bajaj, Harpreet S.
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2259 - 2270
  • [22] Efficacy and Safety Outcomes with Once-Weekly Insulin Icodec vs. Once-Daily Insulin Degludec in Type 1 Diabetes According to Glycemic Variability-ONWARDS 6 Post Hoc Analysis
    Irace, Concetta
    Begtrup, Kamilla
    Marques, Mariana Fragao
    Watt, Sara K.
    Klonoff, David C.
    DIABETES, 2024, 73
  • [23] Improved patient-reported outcomes with once-weekly insulin icodec with a dosing guide app versus once-daily basal insulin analogues in type 2 diabetes (ONWARDS 5)
    Goldenberg, R.
    Benamar, M.
    Carstensen, L.
    Davies, M.
    Donatsky, A. M.
    Franek, E.
    Kellerer, M.
    Polonsky, W.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S398
  • [24] Once-weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant-level meta-analysis of the ONWARDS 1-5 trials
    Bajaj, Harpreet S.
    Asbjoernsdottir, Bjoerg
    Bari, Tanvir J.
    Begtrup, Kamilla
    Vilsboll, Tina
    Rosenstock, Julio
    DIABETES OBESITY & METABOLISM, 2024, 26 (09): : 3810 - 3820
  • [25] Better glycaemic control with once-weekly insulin icodec versus once-daily insulin degludec in adults with insulin-naive type 2 diabetes (ONWARDS 3)
    Lingvay, I.
    Asong, M.
    Desouza, C.
    Gourdy, P.
    Kar, S.
    Vianna, A.
    Vilsboll, T.
    Vinther, S.
    Mu, Y.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S7
  • [26] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
  • [27] Once-weekly Insulin Icodec as Compared to Once-daily Basal Insulins: A Meta-analysis
    Mukhopadhyay, Pradip
    Chatterjee, Purushottam
    Pandit, Kaushik
    Sanyal, Debmalya
    Ghosh, Sujoy
    ENDOCRINE PRACTICE, 2024, 30 (02) : 128 - 134
  • [28] Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3
    Li, Yijun
    Kar, Soumitra
    Li, Congcong
    Liu, Ming
    Luan, Zijian
    Yuan, Guoyue
    Zhong, Xing
    Mu, Yiming
    DIABETES THERAPY, 2025, 16 (04) : 685 - 699
  • [29] Efficacy and safety of once-weekly basal insulin versus once-daily basal insulin in patients with type 2 diabetes: A systematic review and meta-analysis
    Wang, Xinxin
    Xiao, Wei
    Liang, Zhanpeng
    Li, Shixiang
    Tang, Qizhi
    MEDICINE, 2023, 102 (52) : E36308
  • [30] Efficacy and Hypoglycemia Profile of Once-weekly Insulin Icodec vs Once-daily Comparators Across Demographic Subgroups
    Lingvay, Ildiko
    Bache, Julie Krogsdahl
    Desouza, Cyrus, V
    Fragao-Marques, Mariana
    Navarria, Andrea
    Shaikh, Shehla S.
    Vianna, Andre G. D.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,